Stock chart
Ticker: SNDX Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
April 28, 2021 April 26, 2021 B Purchase

Meyers Michael L.

SVP, Chief Medical Officer Officer
500 +3.3%
15.46
7,730 USD
500 +3.3% 15.46 7,730 USD
April 22, 2021 April 22, 2021 B Purchase

Podlesak Dennis

Non-Executive Director
13,967 +47.6%
14.11
197,077 USD
13,967 +47.6% 14.11 197,077 USD
March 3, 2021 March 1, 2021 PS Planned sale

Egros Fabrice

Non-Executive Director
74 -0.5%
24.31
1,799 USD
74 -0.5% 24.31 1,799 USD
March 3, 2021 March 1, 2021 PS Planned sale

Egros Fabrice

Non-Executive Director
10,167 -38.7%
24.31
247,182 USD
10,167 -38.7% 24.31 247,182 USD
Feb. 10, 2021 Feb. 8, 2021 PS Planned sale

Morrison Briggs

Chief Executive Officer Executive Director
35,156 -42.1%
20.55
722,403 USD
35,156 -42.1% 20.55 722,403 USD
Feb. 3, 2021 Feb. 1, 2021 PS Planned sale

Metzger Michael A

President and COO Executive Director
15,000 -45.9%
20.19
302,799 USD
15,000 -45.9% 20.19 302,799 USD
Dec. 3, 2020 Dec. 1, 2020 PS Planned sale

Metzger Michael A

President and COO Executive Director
15,000 -45.9%
22.97
344,513 USD
15,000 -45.9% 22.97 344,513 USD
Nov. 25, 2020 Nov. 23, 2020 S Sale

Ordentlich Peter

Chief Scientific Officer Officer
16,334 -100.0%
22.89
373,924 USD
16,334 -100.0% 22.89 373,924 USD
Nov. 25, 2020 Nov. 23, 2020 S Sale

Ordentlich Peter

Chief Scientific Officer Officer
7,954 -32.7%
23.58
187,594 USD
7,954 -32.7% 23.58 187,594 USD
Nov. 25, 2020 Nov. 23, 2020 S Sale

Ordentlich Peter

Chief Scientific Officer Officer
5,684 -19.0%
23.33
132,603 USD
5,684 -19.0% 23.33 132,603 USD
Nov. 12, 2020 Nov. 10, 2020 S Sale

Morrison Briggs

Chief Executive Officer Executive Director
17,466 -27.3%
20.06
350,312 USD
17,466 -27.3% 20.06 350,312 USD
Nov. 12, 2020 Nov. 9, 2020 S Sale

Morrison Briggs

Chief Executive Officer Executive Director
62,938 -57.5%
20.04
1,261,265 USD
62,938 -57.5% 20.04 1,261,265 USD
Nov. 6, 2020 Nov. 4, 2020 PS Planned sale

Metzger Michael A

President and COO Executive Director
100,000 -85.0%
20.31
2,031,410 USD
100,000 -85.0% 20.31 2,031,410 USD
Feb. 5, 2020 Feb. 4, 2020 B Purchase

Morrison Briggs

Chief Executive Officer
12,500 +39.8%
8.00
100,000 USD
12,500 +39.8% 8.00 100,000 USD
Oct. 11, 2019 Oct. 10, 2019 B Purchase

Morrison Briggs

Chief Executive Officer
11,000 +53.9%
5.40
59,400 USD
11,000 +53.9% 5.40 59,400 USD
May 13, 2019 May 13, 2019 B Purchase

Morrison Briggs

Chief Executive Officer
7,200 +54.5%
7.29
52,517 USD
7,200 +54.5% 7.29 52,517 USD
May 13, 2019 May 9, 2019 B Purchase

Morrison Briggs

Chief Executive Officer
13,200 +inf%
7.56
99,726 USD
13,200 +inf% 7.56 99,726 USD
March 22, 2019 March 21, 2019 B Purchase

Meyers Michael L.

SVP, Chief Medical Officer
104 +1.5%
4.87
506 USD
104 +1.5% 4.87 506 USD
March 22, 2019 March 21, 2019 B Purchase

Meyers Michael L.

SVP, Chief Medical Officer
1,000 +16.3%
4.93
4,930 USD
1,000 +16.3% 4.93 4,930 USD
Nov. 7, 2018 Oct. 30, 2018 PP Planned purchase

Meyers Michael L.

SVP, Chief Medical Officer
200 +9.1%
4.79
958 USD
200 +9.1% 4.79 958 USD
April 3, 2018 April 3, 2018 PS Planned sale

Ordentlich Peter

Chief Scientific Officer
7,500 -100.0%
15.00
112,500 USD
7,500 -100.0% 15.00 112,500 USD
May 19, 2017 May 17, 2017 PS Planned sale

Ordentlich Peter

Chief Scientific Officer
5,000 -100.0%
15.00
75,000 USD
5,000 -100.0% 15.00 75,000 USD
March 8, 2016 March 8, 2016 B Purchase

ROYSTON IVOR

Non-Executive Director
150,000 +25.0%
12.00
1,800,000 USD
150,000 +25.0% 12.00 1,800,000 USD

Page 1